SI1509215T1 - Zdravljenje ali preprecevanje urogenitalne atrofije in njenih simptomov pri zenskah - Google Patents

Zdravljenje ali preprecevanje urogenitalne atrofije in njenih simptomov pri zenskah

Info

Publication number: SI1509215T1
Authority: SI; Slovenia
Prior art keywords: women; prevention; treatment; symptoms; atrophy
Prior art date: 2002-06-06

Application number

SI200330601T

Other languages

English (en)

Inventor

Taru Blom

Paula Groenroos

Kaija Halonen

Pirkko Haerkoenen

Original Assignee

Hormos Medical Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-06

Filing date

2003-05-14

Publication date

2007-02-28

2003-05-14 Application filed by Hormos Medical Ltd filed Critical Hormos Medical Ltd

2007-02-28 Publication of SI1509215T1 publication Critical patent/SI1509215T1/sl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicinal Preparation (AREA)

SI200330601T 2002-06-06 2003-05-14 Zdravljenje ali preprecevanje urogenitalne atrofije in njenih simptomov pri zenskah SI1509215T1 (sl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US38590402P	2002-06-06	2002-06-06
PCT/FI2003/000369 WO2003103649A1 (en)	2002-06-06	2003-05-14	Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women

Publications (1)

Publication Number	Publication Date
SI1509215T1 true SI1509215T1 (sl)	2007-02-28

Family

ID=29736123

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200330601T SI1509215T1 (sl)	2002-06-06	2003-05-14	Zdravljenje ali preprecevanje urogenitalne atrofije in njenih simptomov pri zenskah

Country Status (24)

Country	Link
EP (1)	EP1509215B1 (sl)
JP (1)	JP4362442B2 (sl)
KR (1)	KR100991157B1 (sl)
CN (2)	CN101406464A (sl)
AT (1)	ATE344025T1 (sl)
AU (1)	AU2003227790B2 (sl)
BR (1)	BR0311613A (sl)
CA (1)	CA2484542C (sl)
CY (1)	CY1105787T1 (sl)
DE (1)	DE60309465T2 (sl)
DK (1)	DK1509215T3 (sl)
ES (1)	ES2270025T3 (sl)
HR (1)	HRP20041150B1 (sl)
IL (1)	IL164528A (sl)
MX (1)	MXPA04012220A (sl)
NO (3)	NO334090B1 (sl)
NZ (1)	NZ536118A (sl)
PL (1)	PL214242B1 (sl)
PT (1)	PT1509215E (sl)
RU (1)	RU2317816C2 (sl)
SI (1)	SI1509215T1 (sl)
UA (1)	UA79797C2 (sl)
WO (1)	WO2003103649A1 (sl)
ZA (1)	ZA200408321B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8236861B2 (en)	2004-02-13	2012-08-07	Hormos Medical Corporation	Method for enhancing the bioavailablity of ospemifene
US8642079B2 (en)	2004-02-23	2014-02-04	Hormos Medical Corporation	Solid formulations of ospemifene
US8758821B2 (en)	2004-05-04	2014-06-24	Hormos Medical Ltd.	Oral formulations of ospemifene
SI1742618T1 (sl)	2004-05-04	2012-12-31	Hormos Medical Ltd.	Tekoäśe oralne formulacije ospemifena
CA2654152A1 (en)	2006-06-02	2007-12-13	Pear Tree Women's Health Care	Method of treating atrophic vaginitis
EP2821385B1 (en)	2007-02-14	2016-07-27	Hormos Medical Ltd.	Method for the preparation of therapeutically valuable triphenylbutene derivatives
US7504530B2 (en)	2007-02-14	2009-03-17	Hormos Medical Ltd.	Methods for the preparation of fispemifene from ospemifene
EP2909164A1 (en)	2012-10-19	2015-08-26	Fermion Oy	A process for the preparation of ospemifene
KR102052133B1 (ko)	2017-08-10	2019-12-05	고려대학교 산학협력단	당 부가된 오스페미펜, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5352699A (en) *	1992-04-30	1994-10-04	University Of Massachusetts Medical Center	Use of retinioc acid to treat vaginal atrophy
US5461064A (en) *	1993-12-21	1995-10-24	Eli Lilly And Company	Methods of inhibiting atrophy of the skin and vagina
US5747059A (en) *	1996-01-11	1998-05-05	Novo Nordisk A/S	Atrophy of skin/mucous membrane
IL149990A0 (en) *	2000-01-28	2002-12-01	Endorech Inc	Selective estrogen receptor modulators in combination with estrogens
US20010034340A1 (en) *	2000-03-20	2001-10-25	American Home Products Corporation	Hormone replacement therapy
US6245819B1 (en) *	2000-07-21	2001-06-12	Hormos Medical Oy, Ltd.	Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause

2003
- 2003-05-14 CA CA2484542A patent/CA2484542C/en not_active Expired - Lifetime
- 2003-05-14 RU RU2004138571/14A patent/RU2317816C2/ru active
- 2003-05-14 MX MXPA04012220A patent/MXPA04012220A/es active IP Right Grant
- 2003-05-14 NZ NZ536118A patent/NZ536118A/en not_active IP Right Cessation
- 2003-05-14 ES ES03725238T patent/ES2270025T3/es not_active Expired - Lifetime
- 2003-05-14 AU AU2003227790A patent/AU2003227790B2/en not_active Expired
- 2003-05-14 CN CNA2008101733358A patent/CN101406464A/zh active Pending
- 2003-05-14 CN CNB038128780A patent/CN100448437C/zh not_active Expired - Lifetime
- 2003-05-14 DK DK03725238T patent/DK1509215T3/da active
- 2003-05-14 PL PL372758A patent/PL214242B1/pl unknown
- 2003-05-14 EP EP03725238A patent/EP1509215B1/en not_active Expired - Lifetime
- 2003-05-14 KR KR1020047019843A patent/KR100991157B1/ko active IP Right Grant
- 2003-05-14 WO PCT/FI2003/000369 patent/WO2003103649A1/en active IP Right Grant
- 2003-05-14 UA UAA200500144A patent/UA79797C2/uk unknown
- 2003-05-14 DE DE60309465T patent/DE60309465T2/de not_active Expired - Lifetime
- 2003-05-14 PT PT03725238T patent/PT1509215E/pt unknown
- 2003-05-14 SI SI200330601T patent/SI1509215T1/sl unknown
- 2003-05-14 JP JP2004510768A patent/JP4362442B2/ja not_active Expired - Lifetime
- 2003-05-14 BR BR0311613-1A patent/BR0311613A/pt not_active Application Discontinuation
- 2003-05-14 AT AT03725238T patent/ATE344025T1/de active
2004
- 2004-10-12 IL IL164528A patent/IL164528A/en active IP Right Grant
- 2004-10-14 ZA ZA200408321A patent/ZA200408321B/en unknown
- 2004-10-22 NO NO20044568A patent/NO334090B1/no not_active IP Right Cessation
- 2004-12-02 HR HR20041150A patent/HRP20041150B1/xx not_active IP Right Cessation
2006
- 2006-11-15 CY CY20061101664T patent/CY1105787T1/el unknown
2013
- 2013-09-04 NO NO20131189A patent/NO336612B1/no not_active IP Right Cessation
2015
- 2015-04-22 NO NO20150487A patent/NO339194B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
HRP20041150A2 (en)	2006-03-31
UA79797C2 (en)	2007-07-25
ES2270025T3 (es)	2007-04-01
RU2317816C2 (ru)	2008-02-27
DE60309465D1 (de)	2006-12-14
EP1509215B1 (en)	2006-11-02
NO336612B1 (no)	2015-10-12
HRP20041150B1 (en)	2007-06-30
NO20150487L (no)	2004-12-22
MXPA04012220A (es)	2005-04-08
KR100991157B1 (ko)	2010-11-02
ATE344025T1 (de)	2006-11-15
IL164528A (en)	2010-06-30
CA2484542A1 (en)	2003-12-18
CY1105787T1 (el)	2011-02-02
DK1509215T3 (da)	2007-03-12
PL372758A1 (en)	2005-08-08
EP1509215A1 (en)	2005-03-02
NZ536118A (en)	2007-08-31
WO2003103649A1 (en)	2003-12-18
JP2005532353A (ja)	2005-10-27
CN100448437C (zh)	2009-01-07
PL214242B1 (pl)	2013-07-31
DE60309465T2 (de)	2007-08-30
NO334090B1 (no)	2013-12-09
ZA200408321B (en)	2006-07-26
CN1658851A (zh)	2005-08-24
NO339194B1 (no)	2016-11-14
JP4362442B2 (ja)	2009-11-11
CN101406464A (zh)	2009-04-15
NO20044568L (no)	2004-12-22
PT1509215E (pt)	2007-01-31
RU2004138571A (ru)	2005-06-10
AU2003227790A1 (en)	2003-12-22
KR20050004292A (ko)	2005-01-12
CA2484542C (en)	2010-11-02
NO20131189L (no)	2004-12-22
IL164528A0 (en)	2005-12-18
BR0311613A (pt)	2005-03-08
AU2003227790B2 (en)	2007-11-29

Publication	Publication Date	Title
AU5844901A (en)	2002-02-05	Method for the treatment of climacteric disorders in women during or after the menopause
DE60329001D1 (en)	2009-10-08	8-hydroxychinolinderivate
TWI371276B (en)	2012-09-01	Use of brimonidine for manufacture of a medicament for preventing or reducing severity of sensory hypersensitivity associated with migratine
WO2006099261A3 (en)	2007-05-18	Potent and specific immunoproteasome inhibitors
PL361404A1 (en)	2004-10-04	Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
MY127290A (en)	2006-11-30	New use of flibanserin
TW200420549A (en)	2004-10-16	Thiazole derivatives
IL193628A0 (en)	2009-08-03	Methods and compositions for bactericide, bacteriostatic and anti-inflammation
SI1509215T1 (sl)	2007-02-28	Zdravljenje ali preprecevanje urogenitalne atrofije in njenih simptomov pri zenskah
WO2003092608A3 (en)	2004-01-15	Methionine aminopeptidase-2 inhibitors and methods of use thereof
IL159241A0 (en)	2004-06-01	Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
DE60004996D1 (de)	2003-10-09	Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen
HK1080768A1 (en)	2006-05-04	Use of epothilone derivatives for the treatment ofhyperparathyroidism
AU2002211217A1 (en)	2002-04-29	Method of treating stroke
DE60309926D1 (de)	2007-01-04	Steroid-verbindungen mit anti-tumoraler wirkung
ES2173044A1 (es)	2002-10-01	Glicina, n-(n-l- -glutamil-3-(nitrosotio)-l-valil) y sus aplicaciones.
SI1817029T1 (sl)	2010-01-29	Derivati izoksazola za lajĺ anje nevropatskih boleäśin